Fig. 3.

Immunohistochemical staining shows that treatment with S-1+LNT was associated with increased frequency of CD86⁺ cells in the tumor. a Isotype control of treatment with S-1 alone, b isotype control of treatment with S-1+LNT, c CD11c⁺ of treatment with S-1 alone, d CD11c⁺ with S-1+LNT, e CD86⁺ of treatment with S-1 alone, f CD86⁺ of treatment with S-1+LNT. The original magnification is ×200 for each sample.